A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-10-01
著者
-
Jolliet P.
Clinical Pharmacology Department Chu De Nantes
-
MARTIN J.
Clinical Pharmacology Department, CHU de Nantes
-
DESLANDES G.
Clinical Pharmacology Department, CHU de Nantes
-
DAILLY E.
Clinical Pharmacology Department, CHU de Nantes
-
RENAUD C.
Clinical Pharmacology Department, CHU de Nantes
-
RELIQUET V.
Infectious Diseases Department, CHU de Nantes
-
RAFFI F.
Infectious Diseases Department, CHU de Nantes
-
Raffi F.
Infectious Diseases Department Chu De Nantes
-
Renaud C.
Clinical Pharmacology Department Chu De Nantes
-
Deslandes G.
Clinical Pharmacology Department Chu De Nantes
-
Reliquet V.
Infectious Diseases Department Chu De Nantes
-
Martin J.
Clinical Pharmacology Department Chu De Nantes
-
Dailly E.
Clinical Pharmacology Department Chu De Nantes
関連論文
- High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid e
- A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV
- A simple high performance liquid chromatography assay for monitoring plasma concentrations of tipranavir in HIV infected patients
- Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detecti